A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years.
DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market – Biotech Investments
DocMorris AG / Key word(s): Quarterly / Interim Statement DocMorris continues to grow in the first quarter of 2024 and creates digital access to the